Phathom Pharmaceuticals

Phathom Pharmaceuticals PHAT Stock

$5.30   -3.636360%
Add to favorites
Market Cap
$430.85M
LOW - HIGH [24H]
$5.04 - $5.54
VOLUME [24H]
$1.65M
P/E Ratio
0
Earnings per share
-$1.01
ISIN
US71722W1071
Price   Prediction

Phathom Pharmaceuticals Price Chart

Sorry, that's all we've gotfor now...

Phathom Pharmaceuticals (PHAT) stock price today is 5.3 USD on Tech Market Large (-3.64% on the day). Updated .

Phathom Pharmaceuticals PHAT Financial and Trading Overview

Phathom Pharmaceuticals stock price 5.3 USD
Previous Close 5.5 USD
Open 5.5 USD
Bid 3.93 USD x 200
Ask 6.65 USD x 200
Day's Range 5.1 - 5.54 USD
52 Week Range 5.02 - 18.31 USD
Volume 367.83K USD
Avg. Volume 1.44M USD
Market Cap 422.72M USD
Beta (5Y Monthly) 0.654
PE Ratio (TTM) N/A
EPS (TTM) -1.01 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 19.65 USD

PHAT Valuation Measures

Enterprise Value 818M USD
Trailing P/E N/A
Forward P/E 5.781632
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.5378143
Price/Book (mrq) N/A
Enterprise Value/Revenue 2.976
Enterprise Value/EBITDA -32.741

Trading Information

Phathom Pharmaceuticals Stock Price History

Beta (5Y Monthly) 0.654
52-Week Change -62.81%
S&P500 52-Week Change 10.51%
52 Week High 18.31 USD
52 Week Low 5.02 USD
50-Day Moving Average 6.82 USD
200-Day Moving Average 9.95 USD

PHAT Share Statistics

Avg. Volume (3 month) 1.44M USD
Avg. Daily Volume (10-Days) 1.46M USD
Shares Outstanding 81.29M
Float 65.57M
Short Ratio 5.61
% Held by Insiders 4.60%
% Held by Institutions 89.07%
Shares Short 9.2M
Short % of Float 11.91%
Short % of Shares Outstanding 11.31%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -30.19%
Operating Margin (ttm) -9.26%
Gross Margin 80.67%
EBITDA Margin -9.089%

Management Effectiveness

Return on Assets (ttm) -5.43%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 274.88M USD
Revenue Per Share (ttm) 3.39 USD
Quarterly Revenue Growth (yoy) 71.09%
Gross Profit (ttm) 221.78M USD
EBITDA -24984000 USD
Net Income Avi to Common (ttm) -82996000 USD
Diluted EPS (ttm) -1.01
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 184.56M USD
Total Cash Per Share (mrq) 2.27 USD
Total Debt (mrq) 555.45M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1.761
Book Value Per Share (mrq) -4.28

Cash Flow Statement

Operating Cash Flow (ttm) -20739000 USD
Levered Free Cash Flow (ttm) -12944250 USD

Profile of Phathom Pharmaceuticals

Country United States
State NJ
City Florham Park
Address 100 Campus Drive
ZIP 07932
Phone 877 742 8466
Website https://www.phathompharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 371

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Q&A For Phathom Pharmaceuticals Stock

What is a current PHAT stock price?

Phathom Pharmaceuticals PHAT stock price today per share is 5.3 USD.

How to purchase Phathom Pharmaceuticals stock?

You can buy PHAT shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Phathom Pharmaceuticals?

The stock symbol or ticker of Phathom Pharmaceuticals is PHAT.

Which industry does the Phathom Pharmaceuticals company belong to?

The Phathom Pharmaceuticals industry is Biotechnology.

How many shares does Phathom Pharmaceuticals have in circulation?

The max supply of Phathom Pharmaceuticals shares is 81.29M.

What is Phathom Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Phathom Pharmaceuticals PE Ratio is now.

What was Phathom Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Phathom Pharmaceuticals EPS is -1.01 USD over the trailing 12 months.

Which sector does the Phathom Pharmaceuticals company belong to?

The Phathom Pharmaceuticals sector is Healthcare.

Phathom Pharmaceuticals PHAT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24424.45 USD —
+0.39
6.08B USD — 24225.3 USD — 24538.78 USD — — 6.08B USD —
us US Tech Global Select Market Com NQGS US 12034.87 USD —
+0.42
— — 11933.12 USD — 12087.81 USD — — — —
us US Tech Biotechnology NBI US 6971.7 USD —
-0.66
— — 6959.96 USD — 7076.43 USD — — — —
us US Tech Health Care IXHC US 1324.44 USD —
-0.63
— — 1322.85 USD — 1342.46 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.16T
Total marketcap
$71.35B
Total volume
BTC 58.03%   •   ETH 9.88%
Dominance
Select currency